{"id":"https://openalex.org/W3083312989","doi":"https://doi.org/10.1158/1538-7445.am2020-6714","title":"Abstract 6714: Genetic screens identify T cell co-stimulation as a key modifier of the redirected cytotoxicity of bispecific T cell engager (BiTE\u00ae) molecules","display_name":"Abstract 6714: Genetic screens identify T cell co-stimulation as a key modifier of the redirected cytotoxicity of bispecific T cell engager (BiTE\u00ae) molecules","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083312989","doi":"https://doi.org/10.1158/1538-7445.am2020-6714","mag":"3083312989"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-6714","doi":"https://doi.org/10.1158/1538-7445.am2020-6714","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-6714","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063602889","display_name":"Ye Shen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ye Shen","raw_affiliation_strings":["Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003849228","display_name":"Patrick J. Collins","orcid":"https://orcid.org/0000-0002-7141-7503","observed_orcids":["https://orcid.org/0000-0002-7141-7503"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Collins","raw_affiliation_strings":["Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082981125","display_name":"Jason Samuel Eng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Eng","raw_affiliation_strings":["Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087406082","display_name":"Flordeliza Fajardo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Flordeliza Fajardo","raw_affiliation_strings":["Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103105607","display_name":"Wendy Zhong","orcid":"https://orcid.org/0000-0002-4320-974X","observed_orcids":["https://orcid.org/0000-0002-4320-974X"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Zhong","raw_affiliation_strings":["Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009339982","display_name":"Olivier Nolan-Stevaux","orcid":"https://orcid.org/0000-0002-5934-4786","observed_orcids":["https://orcid.org/0000-0002-5934-4786"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olivier Nolan-Stevaux","raw_affiliation_strings":["Amgen, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, South San Francisco, CA","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"6714","last_page":"6714"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.6406000256538391,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.6406000256538391,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.14319999516010284,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0551999993622303,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9110000133514404},{"id":"https://openalex.org/keywords/t-cell-costimulation","display_name":"T cell costimulation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cd28-costimulation","display_name":"CD28 costimulation","score":0.859000027179718},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.6190000176429749},{"id":"https://openalex.org/keywords/mesothelin","display_name":"mesothelin","score":0.7850000262260437},{"id":"https://openalex.org/keywords/gpi-anchor-biosynthesis","display_name":"GPI anchor biosynthesis","score":0.7089999914169312},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8550000190734863},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.7770000100135803},{"id":"https://openalex.org/keywords/pre-b-all","display_name":"pre-B ALL","score":0.5889999866485596},{"id":"https://openalex.org/keywords/crispr-screening","display_name":"CRISPR screen","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6333048343658447},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.6320364475250244},{"id":"https://openalex.org/C2778020697","wikidata":"https://www.wikidata.org/wiki/Q410189","display_name":"Blinatumomab","level":4,"score":0.5707851052284241},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5275437831878662},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5146023035049438},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5083739161491394},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5008597373962402},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4915405213832855},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4794836938381195},{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.4357985854148865},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.38524118065834045},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3621427118778229},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32378965616226196},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3030727207660675},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.286502480506897},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.21286186575889587},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20467188954353333},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13003361225128174}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-6714","doi":"https://doi.org/10.1158/1538-7445.am2020-6714","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-6714","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.800000011920929}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4212994929","https://openalex.org/W2345455151","https://openalex.org/W2985081230","https://openalex.org/W1724060253","https://openalex.org/W4292087232","https://openalex.org/W4282978053","https://openalex.org/W3198306185","https://openalex.org/W4388048026","https://openalex.org/W3138826711","https://openalex.org/W2539686048"],"abstract_inverted_index":{"Abstract":[0],"BiTE\u00ae":[1,29,82,93,106,131,143,206,217],"constructs":[2],"redirect":[3],"T":[4,16,125,178,291,327,366,433,446],"cell":[5,179,328,332,367,434,447],"cytotoxicity":[6,443],"against":[7],"cancer":[8,24,114,138,318,411],"cells":[9,17,115,126,319,412],"through":[10],"simultaneous":[11],"binding":[12],"to":[13,32,37,74,92,99,161,176,228,231,243,288,395,398,413],"CD3":[14],"on":[15,23,53,290],"and":[18,78,127,269,295,330,339,356,383,469],"a":[19,118,129,146,212,219,283,393,437],"tumor-associated":[20],"antigen":[21],"(TAA)":[22],"cells.":[25,156,292,307],"Blinatumomab,":[26],"an":[27,141,215,362],"anti-CD19":[28],"molecule":[30,107,132,144,285],"used":[31,160],"treat":[33],"pre-B-ALL":[34],"patients,":[35,387],"leads":[36],"more":[38,345],"than":[39,347],"40%":[40],"complete":[41],"remission":[42],"rates.":[43],"Only":[44],"30%":[45],"of":[46,51,60,66,90,152,154,168,200,211,221,274,298,305,310,337,365,376,440,444,454,458],"relapsed":[47,384],"patients":[48,61],"exhibit":[49],"loss":[50,171,375],"CD19":[52],"leukemia":[54],"cells,":[55,139],"indicating":[56,352],"that":[57,104,133,148,286,374,405],"the":[58,88,137,150,183,188,193,201,205,209,232,270,275,441,455,459],"majority":[59],"acquire":[62],"blinatumomab":[63],"resistance":[64,91,173],"independently":[65],"target":[67,155,306,331],"loss.":[68],"Understanding":[69],"such":[70,247],"mechanisms":[71],"could":[72,389,409],"lead":[73],"new":[75],"predictive":[76],"biomarkers":[77],"help":[79],"improve":[80],"current":[81],"immunotherapy.":[83],"To":[84],"gain":[85],"insight":[86],"into":[87],"mechanism":[89],"cytotoxicity,":[94],"we":[95],"performed":[96],"CRISPR":[97],"screens":[98,431],"identify":[100,162,432],"tumor-intrinsic":[101],"genetic":[102],"factors":[103],"modulate":[105],"efficacy":[108],"in":[109,192,224,257,267,317,370,381],"vitro.":[110],"Cas9":[111],"expressing":[112],"human":[113],"transduced":[116],"with":[117,124],"genome-wide":[119],"sgRNA":[120],"library":[121],"were":[122,190,259],"incubated":[123],"either":[128,313,349],"control":[130],"did":[134],"not":[135,260],"recognize":[136],"or":[140,164,174,197,320],"anti-TAA":[142],"at":[145],"concentration":[147],"induced":[149],"lysis":[151],"~90%":[153],"Next-gen":[157],"sequencing":[158],"was":[159,235,279],"enriched":[163,185,277],"depleted":[165],"sgRNA,":[166],"indicative":[167],"genes":[169,222,241,254,265],"whose":[170,255],"confers":[172],"susceptibility":[175],"BiTE\u00ae-mediated":[177,303,343,371,414],"killing.":[180,333,415],"As":[181],"expected,":[182],"most":[184],"candidates":[186,278],"from":[187],"screen":[189,213,238],"involved":[191,223,266],"expression,":[194],"post-translational":[195],"modification":[196],"surface":[198],"presentation":[199],"TAA":[202],"targeted":[203],"by":[204,314,321],"molecules.":[207],"In":[208],"case":[210],"using":[214,322],"anti-MSLN":[216],"molecule,":[218],"panel":[220],"GPI-anchor":[225],"biosynthesis,":[226],"required":[227],"anchor":[229],"MSLN":[230],"plasma":[233],"membrane":[234],"uncovered.":[236],"The":[237],"also":[239,403],"revealed":[240],"known":[242],"promote":[244],"immune":[245],"evasion":[246],"as":[248,250,252,392,436],"PD-L1":[249],"well":[251],"novel":[253],"roles":[256],"immunotherapy":[258],"extensively":[261],"studied":[262],"before,":[263],"including":[264],"apoptosis":[268],"NF-\u03baB":[271],"pathway.":[272],"One":[273],"top":[276],"CD58,":[280],"which":[281],"encodes":[282],"co-stimulatory":[284,368],"binds":[287],"CD2":[289,338],"Genetic":[293,430],"perturbation":[294],"pharmacological":[296],"blockade":[297],"CD58-CD2":[299,311,407],"interaction":[300,312,408],"significantly":[301],"reduced":[302],"killing":[304,344],"Furthermore,":[308],"re-establishment":[309],"overexpressing":[315],"CD58":[316,377],"CD2-agonist":[323],"large":[324],"molecules":[325,450],"improved":[326],"activation":[329],"Moreover,":[334],"concurrent":[335],"blocking":[336,348],"CD28":[340],"co-stimulation":[341,435],"inhibited":[342],"profoundly":[346],"pathway":[350],"alone,":[351],"redundancy":[353],"between":[354],"CD58-":[355],"CD80/86-mediated":[357],"co-stimulation.":[358],"Our":[359,401],"study":[360,402],"reveals":[361],"important":[363],"role":[364],"signals":[369],"cytotoxicity.":[372],"Considering":[373],"is":[378],"highly":[379],"prevalent":[380],"DLBCL":[382],"Hodgkin":[385],"lymphoma":[386],"it":[388],"potentially":[390],"serve":[391],"biomarker":[394],"predict":[396],"response":[397],"BiTE\u00ae-based":[399],"therapies.":[400],"demonstrates":[404],"restoring":[406],"sensitize":[410],"Citation":[416],"Format:":[417],"Ye":[418],"Shen,":[419],"Patrick":[420],"Collins,":[421],"Jason":[422],"Eng,":[423],"Flordeliza":[424],"Fajardo,":[425],"Wendy":[426],"Zhong,":[427],"Olivier":[428],"Nolan-Stevaux.":[429],"key":[438],"modifier":[439],"redirected":[442],"bispecific":[445],"engager":[448],"(BiTE\u00ae)":[449],"[abstract].":[451],"In:":[452],"Proceedings":[453],"Annual":[456],"Meeting":[457],"American":[460],"Association":[461],"for":[462],"Cancer":[463,475],"Research":[464],"2020;":[465],"2020":[466],"Apr":[467],"27-28":[468],"Jun":[470],"22-24.":[471],"Philadelphia":[472],"(PA):":[473],"AACR;":[474],"Res":[476],"2020;80(16":[477],"Suppl):Abstract":[478],"nr":[479],"6714.":[480]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}